Chroma Medicine, Inc.
Total raised
$135 M
1 round on record
Latest round
$135 M
Feb 2023
First round on record
Feb 2023
Today
Private
No later event on record
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Feb 2023 | $135 M | No. 1 | $50 to $250 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Chroma Medicine, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2023).
SEC Form D · Sep 2023
The industry group it chose in its notices: Biotechnology.
SEC Form D · Sep 2023
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Chroma Medicine, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Brett Kaplan | Executive officer | Sep 2023 |
| Catherine Stehman-Breen | Executive officer | Sep 2023 |
| Vic Myer | Executive officer | Sep 2023 |
| Bihua Chen | Director | Sep 2023 |
| Catherine Stehman-Breen | Director | Sep 2023 |
| George Golumbeski | Director | Sep 2023 |
| Jeff Marrazzo | Director | Sep 2023 |
| Kevin Bitterman | Director | Sep 2023 |
| Michael Kelly | Director | Sep 2023 |
| Paola Pozzi | Director | Sep 2023 |
| Thomas Cahill | Director | Sep 2023 |